Seeing Is Believing

Currently out of the existing stock ratings of Richard Newitter, 320 are a BUY (56.94%), 240 are a HOLD (42.7%), 2 are a SELL (0.36%).
Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 66.72% that have a potential upside of 22.89% achieved within 204 days.
Richard Newitter’s has documented 1,119 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PEN, Penumbra at 16-Jan-2026.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 4/21/2021. The price target of $286.67 was fulfilled within 1 day with a profit of $10.46 (3.52%) receiving and performance score of 35.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 20-May-2025
10 days ago
(20-Jan-2026)
2/2 (100%)
$14.68 (21.36%)
212
Buy Since 12-Dec-2023
$80
$-0.29 (-0.36%)
$85
21 days ago
(09-Jan-2026)
5/6 (83.33%)
$-0.62 (-0.77%)
96
Buy Since 19-Aug-2021
$91
$10.71 (13.34%)
$91
2 months 6 days ago
(24-Nov-2025)
8/12 (66.67%)
$14.39 (18.78%)
110
Buy Since 10-May-2023
$98
$17.71 (22.06%)
$95
2 months 17 days ago
(13-Nov-2025)
7/12 (58.33%)
$19.39 (24.67%)
285
Buy Since 15-Apr-2019
$100
$19.71 (24.55%)
$110
2 months 18 days ago
(12-Nov-2025)
8/13 (61.54%)
$22.64 (29.27%)
338
Which stock is Richard Newitter is most bullish on?
Which stock is Richard Newitter is most reserved on?
What Year was the first public recommendation made by Richard Newitter?